1. Home
  2. ENR vs PTGX Comparison

ENR vs PTGX Comparison

Compare ENR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energizer Holdings Inc.

ENR

Energizer Holdings Inc.

HOLD

Current Price

$21.11

Market Cap

1.7B

Sector

Miscellaneous

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$80.21

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENR
PTGX
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
5.4B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
ENR
PTGX
Price
$21.11
$80.21
Analyst Decision
Hold
Strong Buy
Analyst Count
7
9
Target Price
$27.00
$93.00
AVG Volume (30 Days)
1.1M
903.1K
Earning Date
02-03-2026
02-20-2026
Dividend Yield
5.94%
N/A
EPS Growth
538.46
N/A
EPS
3.32
0.72
Revenue
$2,952,700,000.00
$209,217,000.00
Revenue This Year
$2.65
N/A
Revenue Next Year
$1.09
$288.98
P/E Ratio
$6.08
$114.33
Revenue Growth
2.28
N/A
52 Week Low
$16.77
$33.70
52 Week High
$35.90
$96.54

Technical Indicators

Market Signals
Indicator
ENR
PTGX
Relative Strength Index (RSI) 58.58 32.92
Support Level $18.92 $79.18
Resistance Level $20.19 $89.61
Average True Range (ATR) 0.70 3.04
MACD 0.15 -1.19
Stochastic Oscillator 92.41 10.29

Price Performance

Historical Comparison
ENR
PTGX

About ENR Energizer Holdings Inc.

Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: